North America Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023

GlobalData
28 Pages - GLDATA62152
$3,995.00

Summary

GlobalData’s new report, North America Uterine Fibroid Embolization (UFE) Procedures Outlook to 2023, provides key procedures data on the North America Uterine Fibroid Embolization (UFE) Procedures. The report provides procedure volumes within market segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- North America Uterine Fibroid Embolization (UFE) Procedures volumes by segments - Gastric Bypass Procedures, Gastric Banding Procedures, Sleeve Gastrectomy Procedures and Other Methods.
- Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Uterine Fibroid Embolization (UFE) Procedures, Segmentation 4
2.3 Definitions of Procedures Covered in the Report 4
3 Uterine Fibroid Embolization (UFE) Procedures, North America 5
3.1 Uterine Fibroid Embolization (UFE) Procedures, North America, 2009-2023 5
3.2 Uterine Fibroid Embolization (UFE) Procedures, North America, 2009-2016 6
3.3 Uterine Fibroid Embolization (UFE) Procedures, North America, 2016-2023 8
4 Uterine Fibroid Embolization (UFE) Procedures, Canada 10
4.1 Uterine Fibroid Embolization (UFE) Procedures, Canada, 2009-2016 10
4.2 Uterine Fibroid Embolization (UFE) Procedures, Canada, 2016-2023 12
5 Uterine Fibroid Embolization (UFE) Procedures, Mexico 14
5.1 Uterine Fibroid Embolization (UFE) Procedures, Mexico, 2009-2016 14
5.2 Uterine Fibroid Embolization (UFE) Procedures, Mexico, 2016-2023 16
6 Uterine Fibroid Embolization (UFE) Procedures, United States 18
6.1 Uterine Fibroid Embolization (UFE) Procedures, United States, 2009-2016 18
6.2 Uterine Fibroid Embolization (UFE) Procedures, United States, 2016-2023 20
7 Appendix 22
7.1 Research Methodology 23
7.1.1 Coverage 23
7.1.2 Secondary Research 23
7.1.3 Primary Research 24
7.1.4 Market Modeling and Forecasting 25
7.1.5 Company Share Analysis 26
7.1.6 Distribution Share Analysis 27
7.1.7 Benchmarking 27
7.2 GlobalData Consulting 27
7.3 Contact Us 28
7.4 Disclaimer 28

1.1 List of Tables
Table 1: Uterine Fibroid Embolization (UFE) Procedures, North America, 2009-2023 5
Table 2: Uterine Fibroid Embolization (UFE) Procedures, North America, Historic, 2009-2016 7
Table 3: Uterine Fibroid Embolization (UFE) Procedures, North America, Forecast, 2016-2023 9
Table 4: Uterine Fibroid Embolization (UFE) Procedures, Canada, Historic, 2009-2016 11
Table 5: Uterine Fibroid Embolization (UFE) Procedures, Canada, Forecast, 2016-2023 13
Table 6: Uterine Fibroid Embolization (UFE) Procedures, Mexico, Historic, 2009-2016 15
Table 7: Uterine Fibroid Embolization (UFE) Procedures, Mexico, Forecast, 2016-2023 17
Table 8: Uterine Fibroid Embolization (UFE) Procedures, United States, Historic, 2009-2016 19
Table 9: Uterine Fibroid Embolization (UFE) Procedures, United States, Forecast, 2016-2023 21
Table 10: Total Number of Primary Research Participants, General Surgery Market, by Country 25

1.2 List of Figures
Figure 1: Uterine Fibroid Embolization (UFE) Procedures, North America, 2009-2023 5
Figure 2: Uterine Fibroid Embolization (UFE) Procedures, North America, Historic, 2009-2016 6
Figure 3: Uterine Fibroid Embolization (UFE) Procedures, North America, Forecast, 2016-2023 8
Figure 4: Uterine Fibroid Embolization (UFE) Procedures, Canada, Historic, 2009-2016 10
Figure 5: Uterine Fibroid Embolization (UFE) Procedures, Canada, Forecast, 2016-2023 12
Figure 6: Uterine Fibroid Embolization (UFE) Procedures, Mexico, Historic, 2009-2016 14
Figure 7: Uterine Fibroid Embolization (UFE) Procedures, Mexico, Forecast, 2016-2023 16
Figure 8: Uterine Fibroid Embolization (UFE) Procedures, United States, Historic, 2009-2016 18
Figure 9: Uterine Fibroid Embolization (UFE) Procedures, United States, Forecast, 2016-2023 20

$3,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports